Big Pharma is nervous The New York Times writes about the growth of Chinese biotechnology as a challenge for the United States: Chinese clinical trials and new drugs are increasingly being discussed at international oncology forums. The American concern here does not sound like joy for patients, but rather like fear of losing the drug-development dominance . In a normal world

https://www.nytimes.com/2026/05/30/business/china-lung-cancer-drugs-asco.html